Reducing confounding and suppression effects in TCGA data: an integrated analysis of chemotherapy response in ovarian cancer.
about
TopFed: TCGA tailored federated query processing and linking to LODIntegrative network analysis of TCGA data for ovarian cancer.Prediction of resistance to chemotherapy in ovarian cancer: a systematic review.Adverse Drug Events-based Tumor Stratification for Ovarian Cancer Patients Receiving Platinum Therapy.The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical-genomic driver associationsSTAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups.Single-sample expression-based chemo-sensitivity score improves survival associations independently from genomic mutations for ovarian cancer PatientsA mixture copula Bayesian network model for multimodal genomic data.Genetic and molecular analyses reveal G6PC as a key element connecting glucose metabolism and cell cycle control in ovarian cancer.Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy.Synergy evaluation by a pathway-pathway interaction network: a new way to predict drug combination.Molecular features that predict the response to antimetabolite chemotherapies.Selected articles from the IEEE International Workshop on Genomic Signal Processing and Statistics (GENSIPS'2011).A powerful nonparametric method for detecting differentially co-expressed genes: distance correlation screening and edge-count test.
P2860
Q28648128-83EFAD9B-1EEC-4365-A874-8FD376ACC5C6Q30882404-034BFCD0-7461-40B1-ADC1-57BF543224E8Q35212386-B9511420-F5F9-4811-AC2A-27A8F47F9405Q35917300-EB8ABD6E-11CE-4D4C-B6F1-8666C426AE25Q36220226-E910771D-DD26-4069-9770-237FEDEF2754Q36761363-71143005-4145-4198-A47F-F3A556D5A1FDQ36962398-F79CE952-EB70-46F9-A362-166A277CEA04Q37211342-C3D2C0E9-599D-4BDC-A7BC-EC52E3062F71Q38806228-BD1459DB-AD8F-41C3-AC96-4781124F5CF8Q38880714-28C8974C-7726-4B3C-A335-5DC44AC84D4BQ39590420-73754562-1108-481A-93A1-F91221C05B02Q40188819-9EA90C30-8113-46F9-9311-1F0D91A1B1F5Q42281145-8BEA2C47-0391-4DD0-A98E-0DA2281E22E7Q42403254-073ED098-05D3-4F29-9168-8ECEC4966B14Q54956745-93824D1C-A91B-45A6-ABCF-569BFBAD0494
P2860
Reducing confounding and suppression effects in TCGA data: an integrated analysis of chemotherapy response in ovarian cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Reducing confounding and suppr ...... py response in ovarian cancer.
@ast
Reducing confounding and suppr ...... py response in ovarian cancer.
@en
type
label
Reducing confounding and suppr ...... py response in ovarian cancer.
@ast
Reducing confounding and suppr ...... py response in ovarian cancer.
@en
prefLabel
Reducing confounding and suppr ...... py response in ovarian cancer.
@ast
Reducing confounding and suppr ...... py response in ovarian cancer.
@en
P2093
P2860
P1433
P1476
Reducing confounding and suppr ...... py response in ovarian cancer.
@en
P2093
Alexander J R Bishop
Erchin Serpedin
Fang-Han Hsu
Tzu-Hung Hsiao
Yidong Chen
P2860
P2888
P356
10.1186/1471-2164-13-S6-S13
P407
P478
13 Suppl 6
P577
2012-10-26T00:00:00Z
P6179
1048694940